Novem Group’s ResMed RMD Stock Holding History

Novem Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.14M	Buy	5,154 +218	+4%	+$47.6K	0.11%	162
2026 Q2	$962K	Buy	4,936 +492	+11%	+$102K	0.1%	198
2026 Q1	$998K	Buy	4,444 +241	+6%	+$60.1K	0.11%	167
2025 Q4	$1.01M	Buy	4,203 +465	+12%	+$119K	0.12%	180
2025 Q3	$1.02M	Buy	3,738 +129	+4%	+$35.2K	0.12%	161
2025 Q2	$931K	Sell	3,609 -1,096	-23%	-$261K	0.12%	165
2025 Q1	$1.05M	Buy	4,705 +1,152	+32%	+$269K	0.15%	126
2024 Q4	$813K	Buy	+3,553	New	+$855K	0.12%	156

Other funds holding RMD

Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return

Washington Trust Advisors Wellesley, Massachusetts $1.4B AUM 26.88% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return

NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return

Addenda Capital Montreal, Quebec, Canada $3.78B AUM 23.53% 1-Year Est. Return

Novem Group's RMD Position: Q3 2026 in Review

Novem Group increased its ResMed (RMD) stake by 4.4% in Q3 2026, buying an estimated $47.6K and bringing the position to 5,154 shares worth $1.14M. The position accounts for 0.11% of the portfolio, ranked #162.

Novem Group first reported a position in RMD in Q4 2024 and has held it in 8 quarters since. 186 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

Novem Group held 5,154 shares of ResMed worth $1.14M as of Q3 2026.
Novem Group bought 218 ResMed shares in Q3 2026, an estimated $47.6K.
ResMed made up 0.11% of Novem Group's portfolio in Q3 2026, its #162 holding.
Novem Group first reported a position in ResMed in Q4 2024 and has held it in 8 quarters since.
186 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Novem Group's 13F filing for Q3 2026, filed 19 Oct 2026.